Gardner Lewis Asset Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Gardner Lewis Asset Management’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-84,768	Closed	-$1.82M	–	87
2026 Q1	$1.82M	Buy	+84,768	New	+$1.19M	0.39%	55

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Gardner Lewis Asset Management's DAWN Position: Q2 2026 in Review

Gardner Lewis Asset Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 84,768 shares — an estimated $1.82M sold.

Gardner Lewis Asset Management first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $1.82M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Gardner Lewis Asset Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Gardner Lewis Asset Management sold 84,768 Day One Biopharmaceuticals shares in Q2 2026, an estimated $1.82M.
Gardner Lewis Asset Management first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Gardner Lewis Asset Management's Day One Biopharmaceuticals position peaked at $1.82M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Gardner Lewis Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.